Cox-2 inhibition and chemoradiation for squamous cell carcinoma of the head and neck

被引：0
|
作者：
Spencer, S.
Nabell, L.
Bonner, J.
Peters, G.
Carroll, W. L.
Meredith, R.
Clemons, L.
Ove, R.
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] E Carolina Univ, Brody Sch Med, Greenville, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.6065
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6065
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Dual EGFR and COX-2 Inhibition as a Novel Approach to Targeting Head and Neck Squamous Cell Carcinoma
    Kao, J.
    Sikora, A. T.
    Fu, S.
    CURRENT CANCER DRUG TARGETS, 2009, 9 (08) : 931 - 937
  • [2] The role of NOS and COX-2 pathways in head and neck squamous cell carcinoma
    Franchi, A
    UPDATE IN PATHOLOGY, PROCEEDINGS, 2003, : 158 - 160
  • [3] Expression of cycloxygenase-2 (COX-2) in head and neck squamous cell carcinoma cell lines.
    Lee, G
    Mysore, VS
    Wang, MB
    Srivatsan, ES
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (01) : S152 - S152
  • [4] The prognostic significance of COX-2 expression in squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy
    Smid, EJ
    Stoter, TR
    Bloemena, E
    Lafleur, MVM
    Leemans, CR
    van der Waal, I
    Slotman, B
    Langendijk, JA
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S18 - S18
  • [5] COX-2 expression is associated with chemoresistance through cancer stemness property in head and neck squamous cell carcinoma
    Saito, Shin
    Ozawa, Hiroyuki
    Imanishi, Yorihisa
    Sekimizu, Mariko
    Watanabe, Yoshihiro
    Ito, Fumihiro
    Ikari, Yuichi
    Nakahara, Nana
    Kameyama, Kaori
    Ogawa, Kaoru
    CANCER RESEARCH, 2018, 78 (13)
  • [6] Cox-2 and IL-10 Polymorphisms and Association with Squamous Cell Carcinoma of The Head and Neck in a Korean Sample
    Jeong, Seung Won
    Tae, Kyung
    Lee, Seung Hwan
    Kim, Kyung Rae
    Park, Chul Won
    Park, Byung Lae
    Shin, Hyoung Doo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2010, 25 (07) : 1024 - 1028
  • [7] Persistent neck disease after chemoradiation for head and neck squamous cell carcinoma
    Sanders, J. G.
    Smith, K. G.
    Jameson, M. B.
    de Groot, C.
    White, J.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2012, 126 (11): : 1121 - 1126
  • [8] Role of cyclooxygenase-2 (COX-2) expression in tumor progression and survival in the squamous cell carcinoma of the head and neck (HNSCC).
    Choe, MS
    Tighiouart, M
    Rogatko, A
    Muller, S
    Shin, HJ
    Francisco, M
    Papadimitrakopoulou, VA
    Khuri, FR
    Hong, WK
    Chen, Z
    Shin, DM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 502S - 502S
  • [9] Rationale for intralesional valrubicin in chemoradiation of squamous cell carcinoma of the head and neck
    Wani, MK
    Koseki, Y
    Yarber, RH
    Sweatman, TW
    Ahmed, A
    Samant, S
    Hengesteg, A
    Israel, M
    Robbins, KT
    LARYNGOSCOPE, 2000, 110 (12): : 2026 - 2032
  • [10] Locoregionally advanced squamous cell carcinoma of the head and neck: chemoradiation or bioradiation
    Specenier, Pol
    Vermorken, Jan B.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 (03) : 223 - 228
12345